Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA)
Clinical trial NCT05194540 · COMPLETED
Trial details
- NCT number
- NCT05194540
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-13
- Primary completion
- 2023-06-06
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.